FTRE

#1855
Fortrea Holdings Inc. - Common Stock
15.3 9 USD
+3.57%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
15.39
15.39
Range Annuel
3.97
18.67
Changement quotidien
+3.57%
Changement Mensuel
+46.15%
Evolution sur 6 mois
+23.42%
Changement Annuel
+269.95%
Clôture Précédente
14.8 6
Open
15.3 9
Low
15.3 9
High
15.3 9
Volume
116
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 1.46 B
  • Employee 14 K
  • Founded 2023
  • CEO Paul R. N. Kirchgraber
  • Website www.fortrea.com
  • Headquarter North Carolina, United States
  • FIGI BBG01GZF9VY6
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.6
ratio cours/chiffre d'affaires
—

Fortrea Holdings Inc. - Common Stock

Fortrea Holdings Inc. is an American contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries. Its primary business is handling all aspects of clinical trials including phase I through IV clinical trial management, clinical pharmacology, and post-approval services. It handles regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. It focuses on oncology, central nervous system and neurodegenerative, rare diseases, and cell and gene therapies. In the five years ending in 2023, it conducted more than 5,850 clinical trials involving over 1 million subjects. It also conducted over 600 studies for medical device companies. The company is one of the largest participants in the international primate trade and has been criticized for its animal testing practices, most specifically animal testing on non-human primates.

Nouvelles